Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05727176
Title	Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement (FOENIX-CCA4)
Acronym	FOENIX-CCA4
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Taiho Oncology, Inc.
Indications	cholangiocarcinoma
Therapies	Futibatinib
Age Groups:	senior \| adult
Covered Countries	USA \| POL \| ITA \| ESP \| BRA \| AUS \| ARG